Daniela Tirziu, PhD

Dr. Tirziu is a Senior Research Scientist and Associate Director of Academic Research (YCRG) who’s oversaw and served as an instrumental member of numerous, innovative advancements in the cardiovascular medicine, specifically in the fields of atherosclerosis, angiogenesis, myocardial hypertrophy, heart failure and medical devices. Dr. Tirziu’s clinical research is focused on the design, reporting and regulatory documentations for interventional cardiovascular device trials, including First-in-Human, CE Mark, IDE/IND Phase III and IV trials and post marketing studies in the US and worldwide. She has made important contributions to clinical research documents, regulatory documents (clinical trial protocols and study reports) and meta-analyses to guide clinical investigation on several novel cardiovascular devices and cerebral embolic protection devices. Dr. Tirziu's research on the basic science front contributed to the understanding of cellular crosstalk in the heart and unraveled a novel molecular mechanism of endothelium-dependent regulation of myocardial hypertrophy and metabolism.